EBD Group and Generic Pharma 2.0 Announce Pharma Meetings, a New Conference Productivity Platform, to Be Launched at CPhI Madrid on October 9, 2012

EBD GroupErin Righetti, +1-760-930-0500orGeneric Pharma 2.0Asa Cox, +1-705-791-3040

EBD Group, the leading partnering firm for the life science industry, and Generic Pharma 2.0 today announced Pharma Meetings, a meeting planning platform to facilitate engagement among attendees and exhibitors. Pharma Meetings will be launched at CPhI, the world’s leading pharmaceutical networking event with over 29,500 attendees from over 130 countries and 2,200 exhibitors.

Pharma Meetings is a heavyweight networking and planning platform running on EBD Group’s partnering360 online life science professional network. Designed to run alongside events, Pharma Meetings provides users with the key functionality to enhance productivity including personal calendars, meeting location and scheduling tools, and the ability to create group discussions around an event.

Attendees and exhibitors of CPhI who want to take advantage of Pharma Meetings to efficiently connect with peers and enhance their event experience can request an invitation and get further information at .

“We are excited to work with Generic Pharma 2.0 to bring the Pharma Meetings platform to attendees of CPhI in Madrid. It is a simple yet highly effective service that participants can use to profile themselves, their company, products and technologies to a broad spectrum of potential partners and engage with their community,” said Lisa Methley, Head of Partnering Services, EBD Group. “Pharma Meetings in Madrid will enable attendees of CPhI to maximize their meeting availability for potential partners, along with the core functionality to communicate, set up meetings, and log meeting notes on a personal agenda to support effective meeting follow-up.”

“Working with EBD Group on Pharma Meetings in Madrid will give individuals attending CPhI a ‘killer app’ for engaging with potential collaborators at the Feria de Madrid. Leveraging the full capabilities of this virtual platform, users can easily manage the process around the setting up and holding of meetings. In addition, we will also provide tables at the Generic Pharma 2.0 Licensing Pavilion for attendees who want a central meeting location,” said Asa Cox, Founder and CEO, Generic Pharma 2.0.

Pharma Meetings is hosted on partnering360, the life science network with 14,000 executive members. Pharma Meetings communications and connection data is retained in partnering360, allowing delegates to follow up on relationships made during and after the conference.

Demonstrations of the Pharma Meetings "app" will be held during CPhI Madrid in the Generic Pharma 2.0 Licensing Pavillion 7H44 in Finished Dose Hall.

For more information on Pharma Meetings Madrid and how to register, go to

Generic Pharma 2.0 helps companies in the pharmaceutical industry achieve transformational growth through smart ideas and innovative opportunities. It has the largest global network in the industry; offering web-platforms and the highest-level expertise for strategic advice, investments, business development and digital engagement.

It runs the following industry leading websites:

For more information visit

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:

EBD Group’s sophisticated web-based partnering service, , is also used as the partnering engine at numerous third-party events around the world, and is the open online community of life science dealmakers that enhances partnering experiences all year long.

Outside of the conference format, EBD Group’s consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.EBD Group has offices in the USA and Europe.

For more information please visit

Suggested Articles

Sanofi spent months hyping its Tuesday investor event, and new CEO Paul Hudson certainly laid out a different vision for the drugmaker at the confab.

After more than 10 years as partners, Sanofi and Regeneron are splitting up their deal to comarket PCSK9 med Praluent and immunology drug Kevzara.

Fujifilm has completed the first manufacturing facility in Japan to make drug-delivering liposomes to use for cancer fighting drugs it is developing.